HEDIMED stakeholder event

You are cordially invited to attend the Environment & Immune-mediated diseases: Exposomic Insights from the HEDIMED Project HEDIMED, Final Stakeholder Event on Tue 20th May 2025, online.

The EU-funded HEDIMED project started in 2020 investigating the role of the exposome in immune-mediated diseases. The exposome includes all lifetime exposures of an individual covering e.g. infections, microbiome, diet, lifestyle, pollution, and occupational factors. HEDIMED aimed at identifying exposomic determinants that can contribute to the ongoing epidemic of immune-mediated diseases focusing on type 1 diabetes, celiac disease, allergies and asthma, all of which have increased rapidly during the last decades. HEDIMED utilized extensive prospective sample and data series collected from pregnant women and children in large birth cohort studies and used modern molecular profiling and data mining tools to identify exposomic risk and protective factors. HEDIMED also created a toolbox that brings several new technologies and solutions available for various stakeholders.

This event aims to deepen the understanding of the crucial role of the exposome in society and identify new opportunities for disease prevention and intervention.

Date: Tuesday 20 May 2025
Location: Online
Time: 09:00-15:00 CET
Cost: Free, registration required
REGISTER NOW

During this stakeholder event, the HEDIMED team will present the key outcomes of the project and address scientific, technological and policy aspects of this research.

Key topics include:
• Exposomic insights into immune mediated diseases: risk factors, causes, mechanisms
• Common exposomic determinants of immune-mediated diseases
• Innovative technologies and platforms for exposome research
• Policy-related insights related to celiac disease, type 1 diabetes and allergies & asthma
& Panel discussion: “How exposomic insights can shape policies and public health”

We hope to engage with you to further extend the impact of our work. You are warmly welcome to join us online for an inspiring day of learning about the exposome, its impact on immune-mediated diseases, and exchange perspectives with researchers and experts from HEDIMED consortium, as well as with other invited European stakeholders.

Image